Status:
COMPLETED
Prospective, Multicenter Study Assessing a Screening Campaign for Cardiovascular Diseases Risk Factors During SARS-CoV-2 Epidemic
Lead Sponsor:
Elsan
Conditions:
Health Behavior
Cardiovascular Diseases
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this prospective study is to evaluate the impact of an innovative screening campagn (using the medical device "CONSULT STATION®" on french population healthcare . The main aims of this stu...
Detailed Description
Cardiovascular diseases and its complications are the leading cause of death in the world. In France, they are the second leading cause of death after cancer, with over 140,000 deaths each year. The ...
Eligibility Criteria
Inclusion
- Patients informed of the study (information sheet given to patients) and who had not given their opposition to the collection of data for research purposes
- Woman or man aged 18 or over
- Patients registered with a social security scheme
Exclusion
- Patients unable to understand the directives requested for the use of the cabin
- Patients under legal protection
- Patients who have expressed their opposition to the use of their data
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
2400 Patients enrolled
Trial Details
Trial ID
NCT05293379
Start Date
July 1 2021
End Date
July 1 2022
Last Update
December 7 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique de Saint Omer
Blendecques, France, 62575
2
Hôpital Privé Saint Claude
Saint-Quentin, France, 02100
3
Clinique Vauban
Valenciennes, France, 59300
4
Hôpital privé du Hainaut
Valenciennes, France, 59300